癌症引起的骨病的故事来自衰老的骨细胞密室
Jeremy S Frieling1, Conor C Lynch1
1Department of Tumor Microenvironment and Metastasis, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
Cancer research
|December 2, 2024
概括
乳腺癌骨转移加速骨细胞衰老,促进骨的破坏. 针对这些衰老的骨质细胞使用老化药物可能提供一种新的治疗策略,用于管理由癌症引起的骨病.
科学领域:
- 在瘤学瘤学.
- 骨生物学 骨生物学 骨生物学
- 癌症转移 癌症转移
背景情况:
- 癌症引起的骨病显著影响患者的生活质量,导致骨相关事件,如骨损失和骨折.
- 虽然向骨质母细胞和骨质母细胞的疗法改善了结果,但骨转移仍然无法治愈.
- 新兴的研究探讨了骨转移中的肌肉和免疫相互作用,以确定新的治疗点.
研究的目的:
- 为了研究骨细胞在乳腺癌骨转移期间在骨微环境中的作用.
- 在骨转移的背景下,描述骨细胞的衰老过程.
- 评估向衰老骨细胞的治疗潜力.
主要方法:
- 从骨转移性乳腺癌模型中分析骨细胞.
- 在骨细胞中与衰老相关的分泌表型的表征.
- 评估老化药物在抑制骨质再吸收和保持骨质质量的有效性.
主要成果:
- 骨转移性乳腺癌诱导骨细胞过早衰老,标志着与衰老相关的分泌表型.
- 过早的骨细胞衰老增强了骨破坏和骨质细胞形成.
- 老化治疗减少了骨质再吸收,并保持了骨质.
结论:
- 骨细胞在骨转移的"恶性循环"中发挥着至关重要的作用.
- 向衰老的骨细胞代表了一种新的治疗方法,用于管理由癌症引起的骨病.
- 老化剂在缓解骨转移的骨并发症方面表现有前途.
更多相关视频
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell
11.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.6K


